Belgium recommends HPV vacc program

20 May 2007

Belgium has joined Austria, Germany, Italy, France, Norway and Luxemburg in deciding to recommend the vaccination of girls against human papillomavirus to prevent cervical cancer and other HPV diseases.

The High Counsel of Health in Belgium recommends universal HPV vaccination for one cohort of young girls between 10 and 13 years of age, while a catch-up program for the remaining cohorts of girls up to the age of 15 could further increase the benefit for the population and will be considered after an ongoing health-economic evaluation.

Belgian physicians can now suggest HPV vaccination to females aged 14 to 26 years who have not been vaccinated before and have not yet had sexual contact. The vaccination of girls and women aged 14 to 26 years who have not been vaccinated before but who have already had sexual contacts should be evaluated by the physician on a case by case basis. The Belgian healthy authority also recommends the urgent organization of systematic screening for the early detection of cervical cancer and reminds that women must continue screening whether they are vaccinated or not.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight